Concurrently, the upregulation of immune checkpoints on T cells, such as programmed death 1(PD-1) and CTLA-4, enhances binding with programmed death ligand 1 (PD-L1), inducing T cell dysfunction or exhaustion, thereby effectively suppressing anti-tumor responses and facilitating immune escape (13–15). Here, CD274 is linked to neoplasm.